These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31626725)

  • 1. Permanent immunosuppression in SLA/LP-positive autoimmune hepatitis is required although overall response and survival are similar.
    Zachou K; Weiler-Normann C; Muratori L; Muratori P; Lohse AW; Dalekos GN
    Liver Int; 2020 Feb; 40(2):368-376. PubMed ID: 31626725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis.
    Zachou K; Gampeta S; Gatselis NK; Oikonomou K; Goulis J; Manoussakis MN; Renaudineau Y; Bogdanos DP; Dalekos GN
    Liver Int; 2015 Feb; 35(2):660-72. PubMed ID: 25113420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frequency and clinical significance of antibodies to soluble liver antigen/liver pancreas in autoimmune hepatitis: a prospective single-center study.
    Yüksekyayla O; Kina N; Ulaba A; Emin Ergün M; Batibay E; Şimşek C; Yildiz Zeyrek F; Wahlin S; Efe C
    Eur J Gastroenterol Hepatol; 2024 May; 36(5):652-656. PubMed ID: 38477840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)].
    Kanzler S; Bozkurt S; Herkel J; Galle PR; Dienes HP; Lohse AW
    Dtsch Med Wochenschr; 2001 Apr; 126(16):450-6. PubMed ID: 11360449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of mycophenolate mofetil
    Dalekos GN; Arvaniti P; Gatselis NK; Gabeta S; Samakidou A; Giannoulis G; Rigopoulou E; Koukoulis GK; Zachou K
    JHEP Rep; 2022 Dec; 4(12):100601. PubMed ID: 36411768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-soluble liver antigen/liver-pancreas (SLA/LP) antibodies in pediatric patients with autoimmune hepatitis.
    Vitozzi S; Djilali-Saiah I; Lapierre P; Alvarez F
    Autoimmunity; 2002 Dec; 35(8):485-92. PubMed ID: 12765473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay.
    Miyakawa H; Kawashima Y; Kitazawa E; Kawaguchi N; Kato T; Kikuchi K; Imai E; Fujikawa H; Hashimoto E; Schlumberger W
    J Autoimmun; 2003 Aug; 21(1):77-82. PubMed ID: 12892738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis.
    Wies I; Brunner S; Henninger J; Herkel J; Kanzler S; Meyer zum Büschenfelde KH; Lohse AW
    Lancet; 2000 Apr; 355(9214):1510-5. PubMed ID: 10801173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics.
    Baeres M; Herkel J; Czaja AJ; Wies I; Kanzler S; Cancado EL; Porta G; Nishioka M; Simon T; Daehnrich C; Schlumberger W; Galle PR; Lohse AW
    Gut; 2002 Aug; 51(2):259-64. PubMed ID: 12117891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study.
    Efe C; Ozaslan E; Wahlin S; Purnak T; Muratori L; Quarneti C; Yüksel O; Muratori P
    Liver Int; 2013 Feb; 33(2):190-6. PubMed ID: 23295051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis.
    Kanzler S; Weidemann C; Gerken G; Löhr HF; Galle PR; Meyer zum Büschenfelde KH; Lohse AW
    J Hepatol; 1999 Oct; 31(4):635-40. PubMed ID: 10551386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and HLA genotypes in Chinese patients with anti-SLA/LP-positive autoimmune hepatitis.
    Zhang HP; Liu YM; Li Z; Ma YX; Li LJ; Zhao DT; Lou JL; Gao ZH; Yan HP
    Ann Transl Med; 2021 Jan; 9(2):153. PubMed ID: 33569455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease.
    Ma Y; Okamoto M; Thomas MG; Bogdanos DP; Lopes AR; Portmann B; Underhill J; Dürr R; Mieli-Vergani G; Vergani D
    Hepatology; 2002 Mar; 35(3):658-64. PubMed ID: 11870381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The significance of anti-soluble liver antigen/liver-pancreas in diagnosing and typing autoimmune hepatitis].
    Zhao Y; Yan HP; Tan YF; Feng X; Liu Y; Cui D; Ma DM; Li WH; Zhang HP
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):283-6. PubMed ID: 17456317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis.
    Mix H; Weiler-Normann C; Thimme R; Ahlenstiel G; Shin EC; Herkel J; David CS; Lohse AW; Rehermann B
    Gastroenterology; 2008 Dec; 135(6):2107-18. PubMed ID: 18773898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of antibodies to soluble liver antigen/liver pancreas: a large French study.
    Eyraud V; Chazouilleres O; Ballot E; Corpechot C; Poupon R; Johanet C
    Liver Int; 2009 Jul; 29(6):857-64. PubMed ID: 19302185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and laboratory characteristics of anti-soluble liver antigen/liver-pancreas (SLA/LP) autoantibody positive liver disease patients].
    Liu YM; Yan HP; Tan YF; Liu Y; Feng X; Kong SL
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):927-9. PubMed ID: 16381642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Implications of Antibodies to Soluble Liver Antigen in Autoimmune Hepatitis: A PRISMA-Compliant Meta-Analysis.
    Chen ZX; Shao JG; Shen Y; Zhang J; Hua Y; Wang LJ; Qin G
    Medicine (Baltimore); 2015 Jun; 94(23):e953. PubMed ID: 26061326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas.
    Herkel J; Heidrich B; Nieraad N; Wies I; Rother M; Lohse AW
    Hepatology; 2002 Feb; 35(2):403-8. PubMed ID: 11826415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune hepatitis.
    Obermayer-Straub P; Strassburg CP; Manns MP
    J Hepatol; 2000; 32(1 Suppl):181-97. PubMed ID: 10728804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.